Image pharmaphorum Editor Oncology Deep Dive: Oncology 2022 Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. White Papers Sponsored Ensuring successful digital outreach and retention in atopic... Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. Views & Analysis Medical Informatics and Rare Disease: a bridge between two w... Today’s rare disease landscape comprises of around 7,000 different diseases. Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was Load more results
Oncology Deep Dive: Oncology 2022 Eradicating cancer is an ambitious goal for oncologists and life science companies around the world.
White Papers Sponsored Ensuring successful digital outreach and retention in atopic... Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies.
Views & Analysis Medical Informatics and Rare Disease: a bridge between two w... Today’s rare disease landscape comprises of around 7,000 different diseases.
Patients From trial design for patients to trial design with patients... At the 2022 Drug Information Association (DIA) annual meeting last week, it was
News Pharma leaders urge Europe to halt 'slow agony' of decline Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
